Zobrazeno 1 - 10
of 531
pro vyhledávání: '"Hak Choy"'
Autor:
Eric J. Hsu, PhD, Jameson T. Mendel, MD, Kristin A. Ward, MD, Mariam El-Ashmawy, MD, Minjae Lee, PhD, Hak Choy, MD, Kenneth D. Westover, MD, PhD, Dat T. Vo, MD, PhD, Robert D. Timmerman, MD, David J. Sher, MD, Puneeth Iyengar, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100995- (2022)
Purpose: : Five-fraction stereotactic ablative radiotherapy (SABR) regimens are frequently used to treat centrally located early-stage non-small cell lung cancer or disease in the proximity of the chest wall as a means of optimizing tumor control and
Externí odkaz:
https://doaj.org/article/b74d8f81cb8a41bfa5b27c2798aa74a3
Autor:
Arnold Pompos, Robert L. Foote, Albert C. Koong, Quynh Thu Le, Radhe Mohan, Harald Paganetti, Hak Choy
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
In this review, we attempt to make a case for the establishment of a limited number of heavy ion cancer research and treatment facilities in the United States. Based on the basic physics and biology research, conducted largely in Japan and Germany, a
Externí odkaz:
https://doaj.org/article/d7a1fdcfdbc247bb891eed5551a68277
Autor:
Jonathan E. Schoenhals, BS, Osama Mohamad, MD, PhD, Alana Christie, MS, Yuanyuan Zhang, MD, PhD, Daniel Li, MD, Nirmish Singla, MD, MSCS, Isaac Bowman, MD, Waddah Arafat, MD, Hans Hammers, MD, Kevin Courtney, MD, PhD, Suzanne Cole, MD, Aditya Bagrodia, MD, Vitaly Margulis, MD, Neil Desai, MD, Aurelie Garant, MD, Hak Choy, MD, Robert Timmerman, MD, James Brugarolas, MD, PhD, Raquibul Hannan, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100692- (2021)
Purpose: Oligoprogression, defined as limited sites of progression on systemic therapy, in patients with metastatic renal cell carcinoma (mRCC) is not uncommon, possibly because of inter- and intratumoral heterogeneity. We evaluated the effect of ste
Externí odkaz:
https://doaj.org/article/d3d6725df09840e68eee2bfa7aa552b3
Autor:
Raquibul Hannan, Michael Christensen, Alana Christie, Aurelie Garant, Ivan Pedrosa, Liliana Robles, Samantha Mannala, Chiachien Wang, Hans Hammers, Waddah Arafat, Kevin Courtney, Isaac A. Bowman, David Sher, Chul Ahn, Suzanne Cole, Hak Choy, Robert Timmerman, James Brugarolas
Publikováno v:
Eur Urol Oncol
BACKGROUND: Evidence-based guidelines for the management of systemic therapy naïve oligometastatic renal cell carcinoma (RCC) are lacking. This prospective phase II single-arm trial evaluated the potential of stereotactic ablative radiotherapy (SAbR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ddce494cb8664066ee0228c5fb2fe5
https://doi.org/10.1016/j.euo.2022.06.008
https://doi.org/10.1016/j.euo.2022.06.008
Autor:
James Brugarolas, Robert D. Timmerman, Hak Choy, Vitaly Margulis, Tao Wang, Lindsay Cowell, Ivan Pedrosa, Yang-Xin Fu, Edward K. Wakeland, Brandi Cantarel, Kevin Courtney, Yull Arriaga, Mingyi Chen, Payal Kapur, Chul Ahn, Eric J. Hsu, Dan Ishihara, Nancy Monson, Scott Christley, Alana Christie, Samantha Mannala, Ze Zhang, Laurentiu M. Pop, Subrata Manna, Alberto Diaz de Leon, Osama Mohamad, Raquibul Hannan
Supplementary Fig. S2. Trend lines showing pre- and post-treatment values and pre-to-post-treatment change for the Non-Clinically Benefiting (NCB) and Clinically Benefiting (CB) patient groups.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b9ae2b2a13744fa1ff083c637c9ce31
https://doi.org/10.1158/1078-0432.22483067
https://doi.org/10.1158/1078-0432.22483067
Autor:
James Brugarolas, Robert D. Timmerman, Hak Choy, Vitaly Margulis, Tao Wang, Lindsay Cowell, Ivan Pedrosa, Yang-Xin Fu, Edward K. Wakeland, Brandi Cantarel, Kevin Courtney, Yull Arriaga, Mingyi Chen, Payal Kapur, Chul Ahn, Eric J. Hsu, Dan Ishihara, Nancy Monson, Scott Christley, Alana Christie, Samantha Mannala, Ze Zhang, Laurentiu M. Pop, Subrata Manna, Alberto Diaz de Leon, Osama Mohamad, Raquibul Hannan
Purpose:This phase II clinical trial evaluated whether the addition of stereotactic ablative radiotherapy (SAbR), which may promote tumor antigen presentation, improves the overall response rate (ORR) to high-dose IL2 (HD IL2) in metastatic renal cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0adec3b6037668e94333ed6dc1af8aa6
https://doi.org/10.1158/1078-0432.c.6531062
https://doi.org/10.1158/1078-0432.c.6531062
Autor:
James Brugarolas, Robert D. Timmerman, Hak Choy, Vitaly Margulis, Tao Wang, Lindsay Cowell, Ivan Pedrosa, Yang-Xin Fu, Edward K. Wakeland, Brandi Cantarel, Kevin Courtney, Yull Arriaga, Mingyi Chen, Payal Kapur, Chul Ahn, Eric J. Hsu, Dan Ishihara, Nancy Monson, Scott Christley, Alana Christie, Samantha Mannala, Ze Zhang, Laurentiu M. Pop, Subrata Manna, Alberto Diaz de Leon, Osama Mohamad, Raquibul Hannan
Multiple tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317991a4fe036e00c57305bd17a692f9
https://doi.org/10.1158/1078-0432.22483064
https://doi.org/10.1158/1078-0432.22483064
Autor:
Raquibul Hannan, Michael Christensen, Hans Hammers, Alana Christie, Brendan Paulman, Dandan Lin, Aurelie Garant, Waddah Arafat, Kevin Courtney, Isaac Bowman, Suzanne Cole, David Sher, Chul Ahn, Hak Choy, Robert Timmerman, James Brugarolas
Publikováno v:
Eur Urol Oncol
BACKGROUND: Patients with metastatic renal cell carcinoma (mRCC) treated with systemic therapy sometimes progress at limited sites. The best treatment approach for patients with oligoprogression remains unclear. OBJECTIVE: To determine the ability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94054d880c7e451d47f8e17f68cafb30
https://doi.org/10.1016/j.euo.2021.12.001
https://doi.org/10.1016/j.euo.2021.12.001
Autor:
Osama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, Andrew Leiker, Alana Christie, Elizabeth Zhang-Velten, Lakshya Trivedi, Saad Khan, Neil B Desai, Aaron Laine, Kevin Albuquerque, Puneeth Iyengar, Yull Arriaga, Kevin Courtney, David E. Gerber, Hans Hammers, Hak Choy, Robert Timmerman, James Brugarolas, Raquibul Hannan
Publikováno v:
OncoImmunology, Vol 7, Iss 7 (2018)
Integration of hypofractionated body radiotherapy (H-RT) into immune checkpoint inhibitor (ICI) therapy may be a promising strategy to improve the outcomes of ICIs, although sufficient data is lacking regarding the safety and efficacy of this regimen
Externí odkaz:
https://doaj.org/article/1b440311a27840808257a962dd3e4584
Autor:
Zohaib Iqbal, Da Luo, Peter Henry, Samaneh Kazemifar, Timothy Rozario, Yulong Yan, Kenneth Westover, Weiguo Lu, Dan Nguyen, Troy Long, Jing Wang, Hak Choy, Steve Jiang
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205392 (2018)
Deep learning has started to revolutionize several different industries, and the applications of these methods in medicine are now becoming more commonplace. This study focuses on investigating the feasibility of tracking patients and clinical staff
Externí odkaz:
https://doaj.org/article/59acee3e13f74e328ca530ca39f31ae2